|
|
Cite this paper: |
|
|
LIANG Pengjuan, LI Shangyong, WANG Kun, WANG Fang, XING Mengxin, HAO Jianhua, SUN Mi. A thermostable serralysin inhibitor from marine bacterium Flavobacterium sp. YS-80-122[J]. Journal of Oceanology and Limnology, 2018, 36(2): 483-489 |
|
|
|
|
|
|
|
A thermostable serralysin inhibitor from marine bacterium Flavobacterium sp. YS-80-122 |
|
| LIANG Pengjuan1,2, LI Shangyong1,2, WANG Kun1,3, WANG Fang1, XING Mengxin1,2, HAO Jianhua1,2, SUN Mi1,2 |
|
1 Key Laboratory of Polar Fisheries Development, Ministry of Agriculture, Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Qingdao 266071, China;
2 Laboratory for Marine Drugs and Bioproducts, Qingdao National Laboratory for Marine Science and Technology, Qingdao 266071, China;
3 Shanghai Ocean University, Shanghai 201306, China |
|
| Abstract: |
| Serralysin inhibitors have been proposed as potent drugs against many diseases and may help to prevent further development of antibiotic-resistant pathogenic bacteria. In this study, a novel serralysin inhibitor gene, lupI, was cloned from the marine bacterium Flavobacterium sp. YS-80-122 and expressed in Escherichia coli. The deduced serralysin inhibitor, LupI, shows <40% amino acid identity to other reported serralysin inhibitors. Multiple sequence alignment and phylogenetic analysis of LupI with other serralysin inhibitors indicated that LupI was a novel type of serralysin inhibitor. The inhibitory constant for LupI towards its target metalloprotease was 0.64 μmol/L. LupI was thermostable at high temperature, in which 35.6%-90.7% of its inhibitory activity was recovered after treatment at 100℃ for 1-60 min followed by incubation at 0℃. This novel inhibitor may represent a candidate drug for the treatment of serralysin-related infections. |
|
| Key words:
serralysin inhibitor|sequence analysis|kinetic parameter|thermostable
|
|
| Received: 2016-10-13 Revised: |
|
|
|
|
References:
Arumugam S, Gray R D, Lane A N. 2008. NMR structure note:alkaline proteinase inhibitor APRin from Pseudomonas aeruginosa. J. Biomol. NMR, 40(3):213-217.
Bae K H, Kim I C, Kim K S, Shin Y C, Byun S M. 1998. The Leu-3 residue of Serratia marcescens metalloprotease inhibitor is important in inhibitory activity and binding with Serratia marcescens metalloprotease. Arch. Biochem.Biophys., 352(1):37-43.
Bardoel B W, van Kessel K P M, van Strijp J A G, Milder F J. 2012. Inhibition of Pseudomonas aeruginosa virulence:characterization of the AprA-AprI interface and species selectivity. J. Mol. Biol., 415(3):573-583.
Baumann U, Bauer M, Létoffé S, Delepelaire P, Wandersman C. 1995. Crystal structure of a complex between Serratia marcescens metallo-protease and an inhibitor from Erwinia chrysanthemi. J. Mol. Biol., 248(3):653-661.
Dhanaraj V, Ye Q Z, Johnson L L, Hupe D J, Ortwine D F, Dunbar J B Jr, Rubin J R, Pavlovsky A, Humblet C, Blundell T L. 1996. Designing inhibitors of the metalloproteinase superfamily:comparative analysis of representative structures. Drug Des. Discov., 13(3-4):3-14.
Feltzer R E, Gray R D, Dean W L, Pierce W M Jr. 2000.Alkaline proteinase inhibitor of Pseudomonas aeruginosa:interaction of native and N-terminally truncated inhibitor proteins with Pseudomonas metalloproteinases. J. Biol. Chem., 275(28):21 002-21 009.
Feltzer R E, Trent J O, Gray R D. 2003. Alkaline proteinase inhibitor of Pseudomonas aeruginosa:a mutational and molecular dynamics study of the role of n-terminal residues in the inhibition of pseudomonas alkaline proteinase. J. Biol. Chem., 278(28):25 952-25 957.
Hao J H, Sun M. 2015. Purification and characterization of a cold alkaline protease from a psychrophilic Pseudomonas aeruginosa HY1215. Appl. Biochem. Biotechnol., 175(2):715-722.
Hege T, Baumann U. 2001. Protease C of Erwinia chrysanthemi:the crystal structure and role of amino acids Y228 and E189. J. Mol. Biol., 314(2):187-193.
Hege T, Feltzer R E, Gray R D, Baumann U. 2001. Crystal structure of a complex between Pseudomonas aeruginosa alkaline protease and its cognate inhibitor:inhibition by a Zinc-NH2 coordinative bond. J. Biol. Chem., 276(37):35 087-35 092.
Ji X F, Zheng Y, Wang W, Sheng J, Hao J H, Sun M. 2013.Virtual screening of novel reversible inhibitors for marine alkaline protease MP. J. Mol. Graph. Model., 46:125-131.
Kida Y, Higashimoto Y, Inoue H, Shimizu T, Kuwano K. 2008.A novel secreted protease from Pseudomonas aeruginosa activates NF-κB through protease-activated receptors.Cell. Microbiol., 10(7):1 491-1 504.
Kida Y, Inoue H, Shimizu T, Kuwano K. 2007. Serratia marcescens serralysin induces inflammatory responses through protease-activated receptor 2. Infect. Immun., 75(1):164-174.
Kim K S, Kim T U, Kim I J, Byun S M, Shin Y C. 1995.Characterization of a metalloprotease inhibitor protein(SmaPI) of Serratia marcescens. Appl. Environ.Microbiol., 61(8):3 035-3 041.
Létoffé S, Delepelaire P, Wandersman C. 1989. Characterization of a protein inhibitor of extracellular proteases produced by Erwinia chrysanthemi. Mol. Microbiol., 3(1):79-86.
Li S Y, Wang L N, Yang J, Bao J, Liu J Z, Lin S X, Hao J H, Sun M. 2016. Affinity purification of metalloprotease from marine bacterium using immobilized metal affinity chromatography. J. Sep. Sci., 39(11):2 050-2 056.
Liao C H, McCallus D E. 1998. Biochemical and genetic characterization of an extracellular protease from Pseudomonas fluorescens CY091. Appl. Environ.Microbiol., 64(3):914-921.
Louis D, Sorlier P, Wallach J. 1998. Quantitation and enzymatic activity of the alkaline protease from Pseudomonas aeruginosa in culture supernatants from clinical strains.Clin. Chem. Lab. Med., 36(5):295-298.
Wang F, Hao J H, Yang C Y, Sun M. 2010. Cloning, expression, and identification of a novel extracellular cold-adapted alkaline protease gene of the marine bacterium strain YS-80-122. Appl. Biochem. Biotechnol., 162(5):1 497-1 505.
|
|
|
|